Genzyme, a Sanofi (SNY) company, and Isis Pharmaceuticals (ISIS) announce that the FDA has voted...

|By:, SA News Editor

Genzyme, a Sanofi (SNY) company, and Isis Pharmaceuticals (ISIS) announce that the FDA has voted 9 to 6 to support the marketing of Kynamro, or mipomersen sodium, for the treatment of patients with Homozygous Familial Hypercholesterolemia. Isis +15% AH.